title: [Allergic rhinitis in children (author's transl)].
abstract: Some of the problems within the research field of allergology are discussed. The main topic is the new treatment of allergic nasal diseases with a local glucocorticosteroid. Beclomethasone dipropionate (Beconase) can be given intranasally without any risk of systemic side-effects. The drug is found very effective in the treatment of hay fever, vasomotor rhinitis and nasal polypi in adults. In a double-blind crossover trial with 19 hay fever children, aged 8-16 years, 18 preferred the active drug, none preferred the placebo and one had no preference. It is concluded that 400 mug beclomethasone dipropionate a day is a safe and very effective treatment of nasal hay fever symptoms in children.
mesh_terms: D000293:Adolescent; D000367:Age Factors; D001507:Beclomethasone / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D008775:Methylprednisolone / Q000031:analogs & derivatives*; D010919:Placebos; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
chemical_list: D010919:Placebos; D001507:Beclomethasone; D008775:Methylprednisolone
vernacular_title: Allergische Rhinitis bei Kindern